Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Crohn's Disease Clinical Trials

A listing of Crohn's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (282) clinical trials

Wake Research Associates is looking for volunteers for a research study of an investigational drug for moderate to severe Crohn’s disease. The study will test the drug’s safety and effectiveness.

Phase

A research study is evaluating a nutritional intervention for Crohn’s Disease.

Phase N/A

People with Crohn’s Disease are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

GED-0301-CD-001 : A Randomized, double-blind, multicenter study to explore the effect of GED-0301 on endoscopic and clinical outcomes in subjects with active Crohn’s Disease.

Phase N/A

Participation in our Crohn's disease research study is for adults only and may last up to 57 weeks. Qualified participants in our research study may receive: Study-related care and study medication on not cost Compensation for time and travel

Phase

This is a multicenter, Phase III, double-blind, placebo-controlled study evaluating the safety and efficacy of etrolizumab during induction and maintenance treatment of moderate to severely active Crohn's disease (CD) in patients who are anti-tumor necrosis factor (TNF) naive (TNF-naive) and in patients who are refractory or intolerant of tumor necrosis ...

Phase

Does your stomach pain and diarrhea come from Crohn's disease? If so, you may qualify to participate in our research study of an investigational medication.

Phase

RECD3125 is a double-blind, placebo-controlled, parallel-group, multicenter, multiregional, 52-week study to assess the efficacy and safety of rifaximin DR tablets for the induction of clinical remission and endoscopic response at 16 weeks followed by clinical and endoscopic remission after 52 weeks of continuous therapy in subjects with active moderate Crohn's ...

Phase

Is your Crohn's Disease not Properly Controlled by Medication? Wake Research Associates is currently enrolling a research study, testing the safety and effectiveness of investigational doses of an already-approved medicine in individuals with moderate to severe Crohn's disease.

Phase N/A